These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
697 related items for PubMed ID: 15919918
1. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice. Ishikawa E, Nakazawa M, Yoshinari M, Minami M. J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918 [Abstract] [Full Text] [Related]
2. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H. J Immunol; 1999 Aug 15; 163(4):1906-13. PubMed ID: 10438925 [Abstract] [Full Text] [Related]
3. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T. Hum Pathol; 2005 Oct 15; 36(10):1066-73. PubMed ID: 16226105 [Abstract] [Full Text] [Related]
4. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway. Musgrave BL, Phu T, Butler JJ, Makrigiannis AP, Hoskin DW. Exp Cell Res; 1999 Oct 10; 252(1):96-103. PubMed ID: 10502402 [Abstract] [Full Text] [Related]
5. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity. Higuchi H, Bronk SF, Taniai M, Canbay A, Gores GJ. J Pharmacol Exp Ther; 2002 Nov 10; 303(2):461-7. PubMed ID: 12388624 [Abstract] [Full Text] [Related]
6. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. Michowitz Y, Goldstein E, Roth A, Afek A, Abashidze A, Ben Gal Y, Keren G, George J. J Am Coll Cardiol; 2005 Apr 05; 45(7):1018-24. PubMed ID: 15808757 [Abstract] [Full Text] [Related]
7. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639 [Abstract] [Full Text] [Related]
8. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Wu GS, Burns TF, Zhan Y, Alnemri ES, El-Deiry WS. Cancer Res; 1999 Jun 15; 59(12):2770-5. PubMed ID: 10383128 [Abstract] [Full Text] [Related]
9. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus. Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN. Arthritis Rheum; 2004 Feb 15; 50(2):629-39. PubMed ID: 14872508 [Abstract] [Full Text] [Related]
13. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate. Vindrieux D, Réveiller M, Florin A, Blanchard C, Ruffion A, Devonec M, Benahmed M, Grataroli R. J Cell Physiol; 2006 Mar 15; 206(3):709-17. PubMed ID: 16245307 [Abstract] [Full Text] [Related]
16. Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells. Oshima K, Yanase N, Ibukiyama C, Yamashina A, Kayagaki N, Yagita H, Mizuguchi J. Cytokine; 2001 May 21; 14(4):193-201. PubMed ID: 11448118 [Abstract] [Full Text] [Related]